| |
 |
ARTICLES 
|
|
| Combined modality therapy for localized aggressive lymphoma: enough or too much? |
| DL Longo |
|
JCO Sep 1 1989: 1179–1181.
[PDF]
|
 |
| Doctor-patient communication and ethical issues |
| LM Parker |
|
JCO Sep 1 1989: 1182–1183.
[PDF]
|
|
| Moving towards a uniform staging for human immunodeficiency virus- associated Kaposi's sarcoma |
| PA Volberding |
|
JCO Sep 1 1989: 1184–1185.
[PDF]
|
|
|
Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy |
| |
SE Jones, TP Miller, and JM Connors |
| |
JCO Sep 1 1989: 1186–1191.
[Abstract]
[PDF]
|
|
|
Doctor-patient communication about breast cancer adjuvant therapy |
| |
LA Siminoff, JH Fetting, and MD Abeloff |
| |
JCO Sep 1 1989: 1192–1200.
[Abstract]
[PDF]
|
|
|
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee |
| |
SE Krown, C Metroka, and JC Wernz |
| |
JCO Sep 1 1989: 1201–1207.
[Abstract]
[PDF]
|
|
|
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy |
| |
A Elias, L Ryan, A Sulkes, J Collins, J Aisner, and KH Antman |
| |
JCO Sep 1 1989: 1208–1216.
[Abstract]
[PDF]
|
|
|
Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas |
| |
AE Chang, SM Steinberg, M Culnane, MH Lampert, AJ Reggia, CG Simpson, JE Hicks, DE White, JJ Yang, and E Glatstein |
| |
JCO Sep 1 1989: 1217–1228.
[Abstract]
[PDF]
|
|
|
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study |
| |
SE Rivkin, S Green, B Metch, H Glucksberg, N Gad-el-Mawla, JJ Constanzi, B Hoogstraten, J Athens, T Maloney, and CK Osborne |
| |
JCO Sep 1 1989: 1229–1238.
[Abstract]
[PDF]
|
|
|
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow- up of 18 years |
| |
PP Rosen, S Groshen, PE Saigo, DW Kinne, and S Hellman |
| |
JCO Sep 1 1989: 1239–1251.
[Abstract]
[PDF]
|
|
|
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer |
| |
G Falkson, RS Gelman, R Dreicer, DC Tormey, AS Alberts, MA Coccia-Portugal, D Rushing, and JM Bennett |
| |
JCO Sep 1 1989: 1252–1259.
[Abstract]
[PDF]
|
|
|
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results |
| |
SN Wolff, RH Herzig, JW Fay, GL Phillips, HM Lazarus, JM Flexner, RS Stein, JP Greer, B Cooper, and GP Herzig |
| |
JCO Sep 1 1989: 1260–1267.
[Abstract]
[PDF]
|
|
|
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group |
| |
B Lowenberg, R Zittoun, H Kerkhofs, U Jehn, J Abels, L Debusscher, C Cauchie, M Peetermans, G Solbu, and S Suciu |
| |
JCO Sep 1 1989: 1268–1274.
[Abstract]
[PDF]
|
|
|
Primary lymphoma of bone in children |
| |
WL Furman, S Fitch, HO Hustu, T Callihan, and SB Murphy |
| |
JCO Sep 1 1989: 1275–1280.
[Abstract]
[PDF]
|
|
|
Lymphomas presenting as histologically unclassified neoplasms: characteristics and response to treatment |
| |
SJ Horning, EK Carrier, RV Rouse, RA Warnke, and SA Michie |
| |
JCO Sep 1 1989: 1281–1287.
[Abstract]
[PDF]
|
|
|
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma |
| |
SI Bearman, FR Appelbaum, A Back, FB Petersen, CD Buckner, KM Sullivan, HG Schoch, LD Fisher, and ED Thomas |
| |
JCO Sep 1 1989: 1288–1294.
[Abstract]
[PDF]
|
|
|
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy |
| |
DL Longo, E Glatstein, PL Duffey, DC Ihde, SM Hubbard, RI Fisher, ES Jaffe, M Gilliom, RC Young, and VT DeVita, Jr |
| |
JCO Sep 1 1989: 1295–1302.
[Abstract]
[PDF]
|
|
|
A comparative study of the nodular and diffuse variants of lymphocyte- predominant Hodgkin's disease |
| |
A Borg-Grech, JA Radford, D Crowther, R Swindell, and M Harris |
| |
JCO Sep 1 1989: 1303–1309.
[Abstract]
[PDF]
|
|
|
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer |
| |
P Preusser, H Wilke, W Achterrath, U Fink, L Lenaz, A Heinicke, J Meyer, HJ Meyer, and H Buente |
| |
JCO Sep 1 1989: 1310–1317.
[Abstract]
[PDF]
|
|
|
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin |
| |
H Wilke, P Preusser, U Fink, U Gunzer, HJ Meyer, J Meyer, JR Siewert, W Achterrath, L Lenaz, and H Knipp |
| |
JCO Sep 1 1989: 1318–1326.
[Abstract]
[PDF]
|
|
|
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma |
| |
B Reichman, M Markman, T Hakes, W Hoskins, S Rubin, W Jones, L Almadrones, M Ochoa, Jr, D Chapman, and P Saigo |
| |
JCO Sep 1 1989: 1327–1332.
[Abstract]
[PDF]
|
|
|
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer |
| |
ML Slevin, PI Clark, SP Joel, S Malik, RJ Osborne, WM Gregory, DG Lowe, RH Reznek, and PF Wrigley |
| |
JCO Sep 1 1989: 1333–1340.
[Abstract]
[PDF]
|
|
|
A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer |
| |
M Eisenberger, S Krasnow, S Ellenberg, H Silva, J Abrams, V Sinibaldi, D Van Echo, and J Aisner |
| |
JCO Sep 1 1989: 1341–1345.
[Abstract]
[PDF]
|
|
|
Effects of granulocyte-macrophage colony-stimulating factor on in vitro growth of human solid tumors |
| |
SE Salmon and R Liu |
| |
JCO Sep 1 1989: 1346–1350.
[Abstract]
[PDF]
|
|
|
Phase I clinical investigation of amonafide |
| |
R Saez, JB Craig, JG Kuhn, GR Weiss, J Koeller, J Phillips, K Havlin, G Harman, J Hardy, and TJ Melink |
| |
JCO Sep 1 1989: 1351–1358.
[Abstract]
[PDF]
|
|
|
Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance |
| |
MW DeGregorio, JM Ford, CC Benz, and VJ Wiebe |
| |
JCO Sep 1 1989: 1359–1364.
[Abstract]
[PDF]
|
|
| Psychological effects of breast conservation versus mastectomy |
| GJ Margolis and RL Goodman |
|
JCO Sep 1 1989: 1365–1366.
[PDF]
|
|
| Bolus fluorouracil for metastatic colorectal carcinoma? |
| JA Ajani |
|
JCO Sep 1 1989: 1366–1367.
[PDF]
|
|
| Outpatient bone marrow harvesting without general anesthesia |
| EG de Vries, DT Sleijfer, and NH Mulder |
|
JCO Sep 1 1989: 1367–1368.
[PDF]
|
|
